aTyr Pharma (ATYR) PT Lowered to $1 at RBC Capital
Tweet
Share
E-mailGet Alerts ATYR Hot Sheet
Price: $0.48 -9.43%
Rating Summary:
3 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
3 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on aTyr Pharma (NASDAQ: ATYR) to $1.00 (from $1.50) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Kazia Therapeutics (KZIA) PT Raised to $40 at BTIG
- Edison International (EIX) PT Lowered to $63 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
